Go to the list of all blogs
published in Blogs
Apr 21, 2026

Lockheed Martin (LMT): Pulling Back from Peaks but Up +20% YTD on Defense Strength

Key Takeaways

  • Lockheed Martin (LMT) shares have pulled back in recent trading sessions but remain up over +20% year-to-date amid strong defense sector tailwinds.
  • Company secured several major U.S. government contracts in recent weeks, including a $4.7 billion deal for PAC-3 missiles.
  • Q1 2026 earnings report scheduled for imminent release, with analysts eyeing EPS around $6.66.
  • Robust backlog and rising missile demand support long-term growth potential.
  • Analyst consensus leans toward Hold, with average price target near $670.

LMT's Current Market Position

I've been following Lockheed Martin (LMT) closely, and the stock has shown some volatility lately, pulling back from earlier highs despite a strong year-to-date performance. From what I see, this reflects broader market caution ahead of quarterly results and mixed news, with contract wins balanced against uncertainties in international deals. The shares still benefit from elevated defense spending and geopolitical tensions that drive demand for aeronautics, missiles, and space systems. Investor sentiment holds up thanks to a substantial backlog and reliable dividend, making LMT a steady option in the aerospace and defense sector through this market cycle.

Recent Contract Wins Fueling Momentum

One thing that stands out for LMT is the series of major contract awards and milestones in recent weeks, which have helped counter some of the downward price pressure. On April 10, the U.S. Army awarded a $4.7 billion contract to ramp up production of PAC-3 Missile Segment Enhancement (MSE) interceptors, following January's plan to triple output to around 2,000 units annually. This highlights the growing need for air defense amid global conflicts, and shares reacted positively at first before some selling set in.

The order book got another boost on April 14 with a Pentagon contract worth up to $1.9 billion for C-130J Super Hercules maintenance and aircrew training under a 10-year indefinite delivery, indefinite quantity (IDIQ) deal. That same day, Lockheed Martin expanded its venture capital fund to $1 billion, focusing on supply chain resilience and national security tech. In the space segment, a $105 million U.S. Space Force contract arrived on April 16 for GPS ground control upgrades, alongside the April 21 launch of the final GPS III satellite to improve accuracy and resilience.

Earlier on April 1, the Orion spacecraft carried NASA's astronauts toward the Moon, a key step for the Artemis program. On the international front, the U.S. greenlit a potential $11.9 billion sale of combat systems to Germany involving LMT and RTX, though Peru delayed a $2 billion F-16 deal, adding some uncertainty. Jefferies stuck with its Hold rating on April 7-8, nudging the price target up to $640 from $630, showing cautious optimism.

These updates haven't fully stemmed the recent slide—shares are down about 5% over the past week and 7% monthly as of mid-April—amid profit-taking after +20% year-to-date gains and caution before the April 23 Q1 report. Q4 2025 results from late January missed EPS at $5.80 against $6.33 expected but lifted 2026 sales guidance to $77.5 billion. Geopolitical risks keep supporting defense names like LMT, though execution challenges moderate the outlook. I also checked this using Tickeron’s AI Screener to gauge how LMT stacks up against industry peers.

Trending AI Robots for Sector Plays

In my research, I've turned to Tickeron's Trending AI Robots page, which highlights top performers from a library of 351 bots trading thousands of tickers in stocks, ETFs, and crypto. These use strategies like swing trading, trend following, multi-agent systems, and volatility plays across timeframes from 5 minutes to 60 minutes, powered by AI/ML for real-time calls. Standouts show annualized returns up to 168%, win rates to 88%, and profit factors over 11. For example, bots focused on aerospace and defense—like those on the ITA ETF or stocks such as RKLB and KTOS—spot sector opportunities. Only bots suited to current conditions make the list, giving a range of styles, risks, and track records that I've found useful for refining strategies in volatile times.

2026 Outlook and What to Watch

Looking toward the rest of 2026, Lockheed Martin draws strength from a backlog nearing $194 billion, driven by F-35 production ramps, missile restocking, and space programs like Orion and GPS IIIF. Guidance calls for sales around $77.5 billion and free cash flow of $6.5-6.8 billion, backed by rising U.S. defense budgets and allied outlays amid global tensions. I'm watching for growth in hypersonics, next-gen air dominance, and commercial space.

Key monitors include missile output scaling, supply chain steadiness after the VC fund increase, and progress on Foreign Military Sales like the Peru F-16s. Risks encompass U.S. budget cuts, fixed-price overruns, and competition from RTX and Northrop Grumman. Regulatory hurdles on M&A and exports are also on my radar. Strong execution across aeronautics (45% of sales), missiles/space, and rotary systems will be crucial.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: LMT

Momentum Indicator for LMT turns negative, indicating new downward trend

LMT saw its Momentum Indicator move below the 0 level on August 20, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned negative. In of the 78 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for LMT moved out of overbought territory on August 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for LMT turned negative on August 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LMT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

LMT moved above its 50-day moving average on July 23, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LMT crossed bullishly above the 50-day moving average on July 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LMT advanced for three days, in of 348 cases, the price rose further within the following month. The odds of a continued upward trend are .

LMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 307 cases where LMT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.837) is normal, around the industry mean (7.037). P/E Ratio (20.781) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (1.166) is also within normal values, averaging (8.077). Dividend Yield (0.024) settles around the average of (0.017) among similar stocks. P/S Ratio (1.695) is also within normal values, averaging (20.174).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
LMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of components and systems for aerospace and defense use

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
6801 Rockledge Drive
Phone
+1 301 897-6000
Employees
122000
Web
https://www.lockheedmartin.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.